A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 113 participants.
Also called NCT06411275
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 113 participants
- Registry
-
NCT06411275
-
- Other papers using this trial's data
- Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06411275. Randomized; double masking; primary purpose treatment. Start 2022-03-31 (actual); primary completion 2023-01-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- HTD1801
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- HTD1801
- Lead sponsor
- Shenzhen HighTide Biopharmaceutical Ltd.
Record details
- Record id
cardio:ct-nct06411275- Content hash
fbc720e3c7b4f03d45de5cc6d7dd732110d868d442d00659db1c8fe25419abf7